All eighteen names in the table's first two blocks are disclosed holdings. Stance reflects how each is framed in this post: the four names given a full write-up (LVMH, Medpace, Brookfield, Topicus) are Positive; the other fourteen holdings are Neutral — listed with a one-line category rationale, reported rather than re-rated. Walmart and Costco are Negative on an explicit valuation warning; NVIDIA is the yardstick in that comparison. Research legend: QT Qualtrim · SA Seeking Alpha · STK Stock Analysis. Foreign primary listings keep this source's suffixed row ids (GAW.L, JDG.L, HGT.L London; CSU.TO Toronto; TOI.V TSX-V; KPG.AX ASX; DNP.WA Warsaw; EVO.ST Stockholm); LVMH keeps the archive's ADR row id LVMUY though the post writes it as $MC. Written post with no timestamps — the At link opens the article.
| Ticker | Name | Research | View | What he said | At |
|---|---|---|---|---|---|
| LVMUY | LVMH (ADR) | QT · SA | Positive | Worked example, "Basic Human Needs & Desires." "LVMH is built on the fundamental human desire for social status. It doesn't sell purses that hold more, or have better organizational features. It sells exclusivity." The economics follow from that: "Luxury goods are Veblen goods. This means people buy more of it when the price increases. That's exactly why LVMH is such a profitable business." Plus the owner signal — Bernard Arnault "keeps buying more and more of his own company. The Arnault family now owns about 50% (!) of LVMH." | read ↗ |
| MEDP | Medpace Holdings | QT · SA · STK · FA | Positive | Worked example, "Where Rules and Humans Still Win." A CRO running trials end to end, "from recruiting patients to navigating the Food and Drug Administration." The AI answer is three-part: "You can't digitize a blood draw. You need real nurses, real doctors, and real patients"; regulators "demand proof of how it actually works in a human body"; and "one poorly managed trial can wipe out $100 million and 10 years of work overnight." Conclusion: at those stakes "executives want the most trusted partner with the best human judgment." | read ↗ |
| BN | Brookfield Corporation | QT · SA · STK · FA | Positive | Worked example, "Assets that last forever" — and the issue's inversion of the AI trade. "AI can write code and analyze spreadsheets, but it cannot replace physical infrastructure… Brookfield owns the physical stuff that makes AI actually work," from renewable generation to pipelines and ports. "Nobody can just build a competitor overnight. These assets take billions of dollars, decades of permits, and years of construction… the more AI grows, the more valuable Brookfield's assets become. Microsoft and Amazon are already signing deals with Brookfield just to lock in the energy their AI data centers need." Bruce Flatt, "Canada's Warren Buffett," has returned +18% a year for two decades against a stated goal to "double the company every 5 years." | read ↗ |
| TOI.V | Topicus.com | QT · SA · STK | Positive | Worked example, "Specialized Services." "The market is worried AI will disrupt companies like Topicus. As a result, the stock seems to be trading at a wild discount. Free Cash Flow keeps going up while the stock went down heavily." Three reasons the fear is wrong: switching after twenty years "feels like moving a mountain"; "AI might know the law… but it doesn't know how a small-town court in the Netherlands actually runs day to day"; and the software is "cheap to keep, costly to lose." FY25 backs it — revenue +20% to €1,552.3m (4% organic), FCFA2S +23% to €218.7m, plus a €384.9m net investment in Asseco Poland. | read ↗ |
| DNP.WA | Dino Polska | SA · STK | Neutral | Disclosed holding, category "Basic Human Needs & Desires." "Owns medium-sized grocery stores close to where people live in rural Poland… People will always need food, and they'll always prefer to buy it nearby." | read ↗ |
| NVO | Novo Nordisk | QT · SA · STK · FA | Neutral | Disclosed holding, category "Basic Human Needs & Desires": diabetes and obesity drugs, chosen because "Novo Nordisk addresses growing, chronic health conditions." No valuation work in this issue — that arrives eleven days later on the Buy-Hold-Sell sheet. | read ↗ |
| ZTS | Zoetis Inc. | QT · SA · STK · FA | Neutral | Disclosed holding, category "Basic Human Needs & Desires": animal medicines, vaccines and diagnostics, because "people bond with pets and depend on livestock, both needs are ancient." Bought for the portfolio shortly before this issue (see 2026-MAR-05). | read ↗ |
| GAW.L | Games Workshop | QT · SA · STK | Neutral | Disclosed holding, category "Basic Human Needs & Desires." The rationale given is social rather than commercial: "Physical games give people an offline hobby and community." | read ↗ |
| EVO.ST | Evolution AB | QT · SA · STK | Neutral | Disclosed holding, category "Basic Human Needs & Desires": B2B live-dealer casino games, justified with the archive's bluntest durability line — "Gambling has been around for thousands of years." | read ↗ |
| IPAR | Inter Parfums | QT · SA · STK · FA | Neutral | Disclosed holding, category "Basic Human Needs & Desires": licensed fragrance manufacturing and distribution. The one-line rationale is the category thesis in miniature — "AI can't replace fragrances." | read ↗ |
| KPG.AX | Kelly Partners Group Holdings | STK | Neutral | Disclosed holding, category "Where Rules and Humans Still Win." "Taxes and accounting are legally required, and business owners need a trusted advisor to navigate them" — regulation as the demand floor, relationship as the moat. Added to a week later (2026-MAR-15). | read ↗ |
| KNSL | Kinsale Capital Group | QT · SA · STK · FA | Neutral | Disclosed holding, category "Where Rules and Humans Still Win": excess-and-surplus lines, where "insurance is necessary and human judgement is required in the niche and unusual cases." The AI-resistance argument is precisely that the risks are non-standard, so there is no clean dataset to model against. | read ↗ |
| BRO | Brown & Brown | QT · SA · STK · FA | Neutral | Disclosed holding, category "Where Rules and Humans Still Win": an independent brokerage placing cover it does not underwrite, because "finding the right insurance coverage takes experience and relationships." | read ↗ |
| AMP | Ameriprise Financial | QT · SA · STK · FA | Neutral | Disclosed holding, category "Where Rules and Humans Still Win": "The financial industry is heavily regulated and many investors will always want a person to help them make decisions." The moat is stated as a preference for a human counterparty, not as software. | read ↗ |
| V | Visa Inc. | QT · SA · STK · FA | Neutral | Disclosed holding, category "Assets that last forever": the payments network across 200+ countries, where "the network becomes more valuable with every new user, and rebuilding it from scratch would take decades and trillions of dollars." | read ↗ |
| JDG.L | Judges Scientific plc | STK | Neutral | Disclosed holding, category "Assets that last forever": a serial acquirer of precision scientific-instrument makers. The stickiness argument is an installed base rather than a network — "the instruments last decades in labs, and once a researcher depends on one, the consumables and servicing revenue follows for life." | read ↗ |
| CSU.TO | Constellation Software | QT · SA · STK · FA | Neutral | Disclosed holding, category "Specialized Services": vertical market software for "funeral homes, golf courses, or transit authorities," where "switching is so painful and risky that almost nobody does." Added to a week later (2026-MAR-15). | read ↗ |
| HGT.L | HgCapital Trust | STK | Neutral | Disclosed holding, category "Specialized Services": a listed trust backing software for tax, accounting, legal and healthcare — "regulated industries are slow to change and can't afford software failures, making their tools among the hardest to rip out." | read ↗ |
| NVDA | NVIDIA Corporation | QT · SA · STK · FA | Neutral | The yardstick, not a pick: at a 39.9x forward P/E it is cheaper than both Walmart and Costco. Used only to show how far the flight into "AI-proof" businesses has gone. No view on the company itself. | read ↗ |
| WMT | Walmart Inc. | QT · SA · STK · FA | Negative | An explicit valuation warning — the archive's first negative call on Walmart. "Fear is driving investors into 'AI-proof' businesses. Walmart and Costco now trade at higher P/E multiples than NVIDIA." Forward P/E 46.1x against NVIDIA's 39.9x. "Fear makes you want to follow the herd. But overpaying for Walmart or Costco could be a big mistake. Even the best company in the world can be a bad investment if you pay too much." No comment on the business — the objection is entirely price. | read ↗ |
| COST | Costco Wholesale | QT · SA · STK · FA | Negative | The more extreme half of the same warning: a forward P/E of 53.7x, the highest of the three names compared and a third above NVIDIA's. Named with Walmart as the destination of the flight into perceived AI-immunity, and covered by the same verdict — "overpaying for Walmart or Costco could be a big mistake." | read ↗ |
Stance = how each name is framed in this post, not a price rating. Microsoft and Amazon appear only as Brookfield's power customers and get no row; Asseco Poland appears only inside Topicus' results line. The portfolio-fundamentals comparison table and the intrinsic-value chart are published as images. The categorisation method is on the actionable insights page.
A jargon-free summary of the thesis behind each argued name. (Renders on each name's consolidated page.)
LVMH owns Louis Vuitton, Dior, Moët & Chandon and dozens of other luxury names. What it actually sells is not a better handbag — as the post says, it "doesn't sell purses that hold more, or have better organizational features. It sells exclusivity." That distinction is what makes the pricing work.
Economists call these Veblen goods: things people want more as the price rises, because the price is part of the product. A business that can raise prices without losing customers is close to the definition of a good business, and it is not something software can imitate. The second half of the case is ownership — Bernard Arnault keeps buying more of his own company, and the family now holds roughly half of it, so the people running it are exposed to the same outcome as the shareholders.
When a drug company wants to test a new medicine, it hires a contract research organisation like Medpace to run the trial: recruiting the patients, coordinating the doctors, collecting the data and steering the whole thing past the FDA. Medpace is paid for running the trial, not for whether the drug works — so it is not a bet on any one medicine.
The reason this is the post's answer to AI is that the work is physical and legally exposed. "You can't digitize a blood draw"; regulators want evidence from real bodies, not model predictions; and a badly run trial can destroy "$100 million and 10 years of work overnight." When the downside is that large, buyers do not shop on price or novelty — they pick the most trusted operator, which is exactly the position a reputation-based business wants to be in.
Brookfield owns real, physical things — hydro and wind power stations, pipelines, ports, office and industrial property — and it also manages money for pension funds and other institutions, taking fees for doing so. Both halves produce cash that arrives regardless of what happens in software.
The interesting move in this issue is to turn the AI worry upside down. AI does not run on ideas; it runs on electricity and physical logistics, and those take "billions of dollars, decades of permits, and years of construction" to create. So the more AI is built, the more valuable Brookfield's existing assets become — Microsoft and Amazon are already signing contracts with it just to secure power for their data centres. Behind it is Bruce Flatt, nicknamed "Canada's Warren Buffett," who has compounded the business at about 18% a year for twenty years with a stated goal of doubling it every five.
Topicus is the European offshoot of Constellation Software, and it does the same thing: buy small software companies whose product runs one specific type of organisation — a library, a public transit system, a specialist clinic — and keep them forever.
Investors have marked it down on the theory that AI will make such software easy to replace. The post gives three reasons that is wrong, and they are practical rather than technical. Twenty years of accumulated data and process means switching "feels like moving a mountain." The software encodes local rules a general model does not know — "AI might know the law… but it doesn't know how a small-town court in the Netherlands actually runs day to day." And the annual cost is trivial next to the damage of it failing, so nobody is shopping for a cheaper option. Meanwhile the numbers went the other way from the share price: 2025 revenue rose 20% and the free cash flow available to shareholders rose 23%.
Nothing here is a criticism of Walmart as a business. The objection is what people are paying for it. Frightened of anything AI might disrupt, investors have crowded into shops and warehouses — things that obviously still need to exist — and pushed Walmart to about 46 times next year's expected earnings.
The comparison that makes the point is that NVIDIA, the company at the centre of the AI boom, trades at about 40 times. So the "safe" choice is now the more expensive one. The underlying rule is the one the archive repeats constantly: "Even the best company in the world can be a bad investment if you pay too much." Buying safety at a high enough multiple stops being safe.
Costco is the more extreme version of the same problem. At roughly 54 times expected earnings it is the most expensive of the three companies compared in this issue — a third dearer than NVIDIA — for a membership warehouse retailer whose profits grow at a fraction of the pace.
The post's diagnosis is behavioural, not analytical: "fear is driving investors into 'AI-proof' businesses," and fear makes people follow the crowd. The consequence is that the multiple, not the business, becomes the risk. It is a useful reminder that a derating can come from a starting price rather than from anything going wrong.
Summary derived from the archived Compounding Quality post (text in transcript.txt) for personal study. Not investment advice. © Compounding Quality / Pieter Slegers for source material.